Drug regulators, pharma firms step up action on fake and substandard drugs
Detection of spurious and substandard drugs was up by 47% from 2020 to 2021, according to an ASPA Report
Detection of spurious and substandard drugs was up by 47% from 2020 to 2021, according to an ASPA Report